跳至主要内容
临床试验/NCT06043583
NCT06043583招募中不适用

Intrauterine Device Versus Uterine Artery Embolization for Adenomyosis: A Randomized Controlled Trial Comparing Therapeutic Efficacy

Yonsei University1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2023年7月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
56
试验地点
1
主要终点
Hemoglobin level

研究概览

简要总结

The primary purpose of this study is to compare the therapeutic efficacy of intrauterine device and uterine artery embolization for uterine adenomyosis.

详细描述

Screening

  • History, Physical examination
  • Laboratory test (Hemoglobin) / MRI
  • Pictorial blood loss assessment chart
  • Symptom/Quality of life score

Intervention

  • Intrauterine device or uterine artery embolization
  • Adverse event montoring

Follow-up visit #1 (1 month)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 48 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women with symptomatic fibroids (age: 19 - 48 years old)
  • Hemglobin < 12g/dL,
  • Symptoms of adenomysis (Menorrhagia, Dysmenorrhea)

排除标准

  • Gynecologic malignancy
  • Ongoing infection or inflammation
  • Coagulopathy (platelet < 50,000 or INR > 1.5)
  • Concomitant endometriosis

结局指标

主要结局

Hemoglobin level

时间窗: Hemoglobin level at 6 and 12 months after each procedure

Hemoglobin as an indicator of menstrual bleeding

次要结局

  • Uterine volume(0,12 months)
  • Pictorial blood loss assessment chart (PBAC)(0,6,12 months)
  • Visual analogue scale(0,6,12 months)
  • Symptom and quality of life score questionnaire(0,6,12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验